CN100480258C - 纯化的黄体生成激素 - Google Patents

纯化的黄体生成激素 Download PDF

Info

Publication number
CN100480258C
CN100480258C CNB018053645A CN01805364A CN100480258C CN 100480258 C CN100480258 C CN 100480258C CN B018053645 A CNB018053645 A CN B018053645A CN 01805364 A CN01805364 A CN 01805364A CN 100480258 C CN100480258 C CN 100480258C
Authority
CN
China
Prior art keywords
luteinizing hormone
column
recombinant human
pharmaceutical composition
hlh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB018053645A
Other languages
English (en)
Chinese (zh)
Other versions
CN1404486A (zh
Inventor
G·帕拉迪斯
M·罗西
L·斯卡利亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Laboratoires Serono SA
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono SA, Applied Research Systems ARS Holding NV filed Critical Laboratoires Serono SA
Publication of CN1404486A publication Critical patent/CN1404486A/zh
Application granted granted Critical
Publication of CN100480258C publication Critical patent/CN100480258C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Semiconductor Lasers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB018053645A 2000-02-22 2001-01-22 纯化的黄体生成激素 Expired - Lifetime CN100480258C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103692.0 2000-02-22
EP00103692 2000-02-22

Publications (2)

Publication Number Publication Date
CN1404486A CN1404486A (zh) 2003-03-19
CN100480258C true CN100480258C (zh) 2009-04-22

Family

ID=8167926

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018053645A Expired - Lifetime CN100480258C (zh) 2000-02-22 2001-01-22 纯化的黄体生成激素

Country Status (30)

Country Link
US (2) US7053054B2 (cg-RX-API-DMAC7.html)
EP (2) EP1261622B1 (cg-RX-API-DMAC7.html)
JP (1) JP4959898B2 (cg-RX-API-DMAC7.html)
KR (1) KR100808149B1 (cg-RX-API-DMAC7.html)
CN (1) CN100480258C (cg-RX-API-DMAC7.html)
AT (1) ATE356138T1 (cg-RX-API-DMAC7.html)
AU (1) AU780377B2 (cg-RX-API-DMAC7.html)
BG (1) BG65761B1 (cg-RX-API-DMAC7.html)
BR (2) BR122012018280B8 (cg-RX-API-DMAC7.html)
CA (1) CA2399100C (cg-RX-API-DMAC7.html)
CY (1) CY1108056T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ303274B6 (cg-RX-API-DMAC7.html)
DE (1) DE60127100T2 (cg-RX-API-DMAC7.html)
DK (1) DK1261622T3 (cg-RX-API-DMAC7.html)
EA (1) EA004385B1 (cg-RX-API-DMAC7.html)
EE (1) EE04932B1 (cg-RX-API-DMAC7.html)
ES (1) ES2278722T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20020651B1 (cg-RX-API-DMAC7.html)
HU (1) HU227007B1 (cg-RX-API-DMAC7.html)
IL (2) IL151309A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02007867A (cg-RX-API-DMAC7.html)
NO (1) NO328693B1 (cg-RX-API-DMAC7.html)
PL (1) PL207728B1 (cg-RX-API-DMAC7.html)
PT (1) PT1261622E (cg-RX-API-DMAC7.html)
RS (1) RS50416B (cg-RX-API-DMAC7.html)
SI (1) SI1261622T1 (cg-RX-API-DMAC7.html)
SK (1) SK287041B6 (cg-RX-API-DMAC7.html)
UA (2) UA92145C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001062774A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200206108B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020651B1 (en) * 2000-02-22 2011-01-31 Laboratoires Serono Sa Purified lh
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE602004030546D1 (de) * 2003-03-04 2011-01-27 Aspenbio Pharma Inc LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers.
CN1283792C (zh) * 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
ATE446314T1 (de) * 2003-12-22 2009-11-15 Ares Trading Sa Methode zur reinigung von fsh
ATE469912T1 (de) * 2004-10-04 2010-06-15 Novetide Ltd Gegenionenaustauschverfahren für peptide
EP1809663B1 (en) * 2004-11-09 2008-09-17 Ares Trading S.A. Method for purifying fsh
US20080219952A1 (en) * 2005-08-26 2008-09-11 Ares Trading S.A. Process For the Preparation of Glycosylated Interferon Beta
JP5199112B2 (ja) * 2005-12-09 2013-05-15 アレス トレーディング ソシエテ アノニム Fsh又はfsh変異体を精製するための方法
EP2203465A1 (en) * 2007-10-22 2010-07-07 Merck Serono S.A. Method for purifying an fc-containing protein
CA2702448A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying fc-fusion proteins
CN101928342B (zh) * 2009-06-18 2013-05-08 上海天伟生物制药有限公司 一种高纯度绝经期促性腺素及其制备方法和用途
WO2015168622A1 (en) * 2014-05-01 2015-11-05 Virginia Tech Intellectual Properties, Inc. Keratin nanomaterials and methods of production
CN104569441B (zh) * 2015-01-19 2016-02-03 成都大熊猫繁育研究基地 大熊猫尿液促黄体素的酶联检测方法及其应用
CA3140267A1 (en) 2019-05-16 2020-11-19 Ceva Sante Animale Compositions and methods for increasing reproduction performance in non-human mammals using recombinant luteinizing hormone

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002757A1 (en) * 1988-09-02 1990-03-22 Integrated Genetics, Inc. Heteropolymeric protein
WO1990009800A1 (en) * 1989-02-21 1990-09-07 Washington University Modified forms of reproductive hormones
WO1998058957A3 (en) * 1997-06-25 1999-04-22 Applied Research Systems Disulfide cross-linked glycoprotein hormone analogs, their preparation and use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
HRP20020651B1 (en) * 2000-02-22 2011-01-31 Laboratoires Serono Sa Purified lh

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002757A1 (en) * 1988-09-02 1990-03-22 Integrated Genetics, Inc. Heteropolymeric protein
WO1990009800A1 (en) * 1989-02-21 1990-09-07 Washington University Modified forms of reproductive hormones
WO1998058957A3 (en) * 1997-06-25 1999-04-22 Applied Research Systems Disulfide cross-linked glycoprotein hormone analogs, their preparation and use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
生物化学中应用的离子交换介质简介. 王佳兴.离子交换与吸附,第8卷第4期. 1992 *

Also Published As

Publication number Publication date
SI1261622T1 (sl) 2007-06-30
HUP0301814A3 (en) 2004-10-28
ZA200206108B (en) 2003-07-31
NO20023963L (no) 2002-08-20
UA92145C2 (en) 2010-10-11
YU60302A (sh) 2005-09-19
AU780377B2 (en) 2005-03-17
HRP20020651B1 (en) 2011-01-31
EP1777231A2 (en) 2007-04-25
JP4959898B2 (ja) 2012-06-27
HU227007B1 (en) 2010-04-28
EP1777231A3 (en) 2007-11-07
ES2278722T3 (es) 2007-08-16
KR100808149B1 (ko) 2008-02-29
WO2001062774A3 (en) 2002-03-14
BG65761B1 (bg) 2009-10-30
PT1261622E (pt) 2007-04-30
AU3543601A (en) 2001-09-03
HUP0301814A2 (hu) 2003-08-28
KR20030001358A (ko) 2003-01-06
EP1261622A2 (en) 2002-12-04
CY1108056T1 (el) 2013-09-04
BRPI0108553B8 (pt) 2021-05-25
EA004385B1 (ru) 2004-04-29
EE200200464A (et) 2003-12-15
HRP20020651A2 (en) 2004-12-31
DE60127100D1 (de) 2007-04-19
MXPA02007867A (es) 2003-02-10
SK287041B6 (sk) 2009-10-07
SK12052002A3 (sk) 2002-12-03
HK1052014A1 (zh) 2003-08-29
US20030186893A1 (en) 2003-10-02
IL151309A0 (en) 2003-04-10
BR122012018280B1 (pt) 2018-01-09
CN1404486A (zh) 2003-03-19
PL362891A1 (en) 2004-11-02
BR122012018280B8 (pt) 2021-05-25
NO328693B1 (no) 2010-04-26
RS50416B (sr) 2009-12-31
UA78676C2 (en) 2007-04-25
US7053054B2 (en) 2006-05-30
CA2399100A1 (en) 2001-08-30
CZ20022856A3 (cs) 2003-01-15
ATE356138T1 (de) 2007-03-15
NO20023963D0 (no) 2002-08-20
EA200200893A1 (ru) 2003-02-27
DK1261622T3 (da) 2007-05-29
PL207728B1 (pl) 2011-01-31
CZ303274B6 (cs) 2012-07-11
US20060079460A1 (en) 2006-04-13
CA2399100C (en) 2011-11-08
BG107001A (bg) 2003-04-30
EE04932B1 (et) 2007-12-17
BR0108553A (pt) 2003-12-23
EP1261622B1 (en) 2007-03-07
JP2003532636A (ja) 2003-11-05
IL151309A (en) 2010-11-30
DE60127100T2 (de) 2007-06-28
BRPI0108553B1 (pt) 2016-06-14
WO2001062774A2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
RS60302B1 (sr) Inhibitori bromodomena
CN100482679C (zh) 人绒毛膜促性腺激素的纯化方法
JP4959898B2 (ja) Lhの精製
HK1052014B (en) Purified lh
HK1052016B (en) Process of purification of hcg

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
ASS Succession or assignment of patent right

Owner name: SERONO LABORATORY CO., LTD.

Free format text: FORMER OWNER: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

Effective date: 20080516

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20080516

Address after: Swiss Coyne Hince

Applicant after: Serono Lab

Address before: Curacao, Netherlands Antilles

Applicant before: Applied Research Systems ARS Holding N. V.

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1052014

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: MERCK SERONO CO., LTD.

Free format text: FORMER OWNER: SERONO LABORATORIES LTD.

Effective date: 20100322

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: COINSINS, SWITZERLAND TO: SWITZERLAND COINSIMS

TR01 Transfer of patent right

Effective date of registration: 20100322

Address after: Coinsin, Switzerland

Patentee after: Merck Serono S. A.

Address before: Swiss Coyne Hince

Patentee before: Serono Lab

CX01 Expiry of patent term

Granted publication date: 20090422

CX01 Expiry of patent term